Medicare Enrolled

Dr. Alan Zausner Skarbnik, MD

Hematology & Oncology · Charlotte, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
125 QUEENS RD STE 610, Charlotte, NC 28204
9803026600
In practice since 2010 (16 years)
NPI: 1366754954 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zausner Skarbnik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zausner Skarbnik? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zausner Skarbnik

Dr. Alan Zausner Skarbnik is a hematology & oncology specialist in Charlotte, NC, with 16 years of NPI registration. Based on federal Medicare data, Dr. Zausner Skarbnik performed 231 Medicare services across 96 unique beneficiaries.

Between the years covered by Open Payments, Dr. Zausner Skarbnik received a total of $1,031,957 from 39 pharmaceutical and/or device companies across 885 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zausner Skarbnik is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ 231 Medicare services $1,031,957 industry payments

Medicare Practice Summary

Medicare Utilization ↗
231
Medicare services
Bottom 30% in NC for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
96
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~14 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
156 $89 $283
New patient office visit, complex (60-74 min) 24 $130 $614
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
20 $109 $425
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
16 $87 $345
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
15 $115 $562
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,031,957
Total received (2018-2024)
Avg $147,422/year across 7 years
Top 1% in NC for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
885
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$970,930 (94.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$58,443 (5.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,584 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$123,240
2023
$241,562
2022
$173,706
2021
$135,845
2020
$77,278
2019
$154,772
2018
$125,554

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$47,847
Lilly USA, LLC
$16,249
ABBVIE INC.
$13,646
E.R. Squibb & Sons, L.L.C.
$10,804
JAZZ PHARMACEUTICALS INC.
$9,636
ADC Therapeutics America, Inc.
$9,461
Kite Pharma, Inc.
$8,726
AstraZeneca UK Limited
$4,845
Genmab U.S., Inc.
$1,011
Celgene Corporation
$638
Genentech USA, Inc.
$123
PFIZER INC.
$117
Epizyme, Inc.
$89
Genentech, Inc.
$31
Novartis Pharmaceuticals Corporation
$19
Top 3 companies account for 63.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$329,096
Kite Pharma, Inc.
$116,612
Lilly USA, LLC
$77,704
AbbVie, Inc.
$74,871
Janssen Biotech, Inc.
$54,193
BeiGene USA, Inc.
$51,902
Pharmacyclics LLC, An AbbVie Company
$49,053
Genentech USA, Inc.
$39,146
JAZZ PHARMACEUTICALS INC.
$38,259
ADC Therapeutics America, Inc.
$37,966
Celgene Corporation
$20,084
AbbVie Inc.
$19,353
ABBVIE INC.
$18,751
Seagen Inc.
$17,772
Seattle Genetics, Inc.
$16,136
E.R. Squibb & Sons, L.L.C.
$12,290
Epizyme, Inc.,
$10,623
Alexion Pharmaceuticals, Inc.
$8,338
Jazz Pharmaceuticals Inc.
$7,525
Verastem, Inc.
$6,928
AstraZeneca UK Limited
$6,778
Genmab U.S., Inc.
$6,731
Gilead Sciences, Inc.
$5,337
Novartis Pharmaceuticals Corporation
$1,504
Genentech, Inc.
$1,351
MorphoSys, US Inc.
$1,338
TG THERAPEUTICS, INC.
$556
Adaptive Biotechnologies Corporation
$303
GENZYME CORPORATION
$258
Incyte Corporation
$207
Ipsen Biopharmaceuticals, Inc
$140
Secura Bio, Inc.
$128
SECURA BIO, INC.
$118
PFIZER INC.
$117
Celularity Inc.
$111
Roche Diagnostics Corporation
$99
Agios Pharmaceuticals, Inc.
$98
TG Therapeutics, Inc.
$96
Epizyme, Inc.
$89
Top 3 companies account for 50.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Adcetris · BRUKINSA · CALQUENCE · COPIKTRA · Columvi · Copiktra · DEFITELIO · DIS Navify Software · Defitelio · ELITEK · EPKINLY · Epkinly · FARYDAK · GAZYVA · IMBRUVICA · Imbruvica · JAKAFI · JAYPIRCA · JCAR017 · KYMRIAH · LUMOXITI · MONJUVI · Pomalyst · Revlimid · Rituxan · TAZVERIK · TIBSOVO · Tazverik · Tecartus · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · Venclexta · Yescarta · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology & oncology in NC.

Looking for a hematology & oncology specialist in Charlotte?
Compare hematology & oncology specialists in the Charlotte area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
43
Per 100K population
3.8
County median income
$83,765
Nearest hospital
CAROLINAS MEDICAL CENTER/BEHAV HEALTH
1.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Zausner Skarbnik is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of NC peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Zausner Skarbnik experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Zausner Skarbnik performed 156 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zausner Skarbnik receive payments from pharmaceutical companies?
Yes. Dr. Zausner Skarbnik received a total of $1,031,957 from 39 companies across 885 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zausner Skarbnik's costs compare to other hematology & oncology specialists in Charlotte?
Dr. Zausner Skarbnik's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zausner Skarbnik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →